City of Hope National Medical Center
Also known as: Beckman Research Institute | Beckman Research Institute of City of Hope | City of Hope Comprehensive Cancer Center | City of Hope Comprehensive Cancer Center, Duarte, CA, USA | City of Hope Comprehensive Cancer Center LAO | City of Hope Comprehensive Center | City of Hope Medical Center | City of Hope Medical Cneter | City of Hope National Cancer Center | City of Hope National Medical Center | City of Hope National Medical Center, Duarte, CA | City of Hope National Medical Center, USA | Clinical Professor of Pediatrics, City of Hope National Medical Center, Dept. of Pediatrics, 1500 E. Duarte Rd. Duarte, CA 91010 | Department of Medical Oncology & Therapeutics Research, City of Hope | Mohamed Elsayed
Highest phase reached
Phase 4
First clinical trial
Sep 1, 1994Last known activity
Dec 15, 2026
Timeline
1910s
- Jan 1, 1913
City of Hope National Medical Center— Founded
Drugs by trial phase (408 distinct, 553 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (30 own, 0 via acquisition)
Phase 2 (218 own, 0 via acquisition)
Phase 1 (125 own, 0 via acquisition)
- di-leu16-il2
- lutetium (177Lu) vipivotide tetraxetan
- fluorothymidine
- Ga 68 PSMA-11
- 7-hydroxystaurosporine
- amg-232
- autologous cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t cells
- avelumab
- azeliragon
- bendamustine
- binimetinib
- bosentan
- brigatinib
- calaa-01
- carboxylesterase-expressing allogeneic neural stem cells
- +110 more
Other trials (31 own, 0 via acquisition)
- piflufolastat
- mdx1201-a488
- bafetinib
- it-101
- deferasirox
- foscarnet
- genetically-modified neural stem cells expressing e.coli cytosine deaminase
- bone marrow derived mesenchymal stem cells
- ritonavir
- ytttrium-90 microspheres
- ketorolac
- lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells
- fluoxetine
- bifidus regularis
- cu64 trastuzumab
- +16 more
Indications
Studied for
- Acute Disease
- Adenocarcinoma
- Adenocarcinoma, Bronchiolo-Alveolar
- Adenocarcinoma of Lung
- Amyloidosis
- Anemia
- Anemia, Hemolytic
- Anemia, Hemolytic, Autoimmune
- Anemia, Refractory
- Anemia, Refractory, with Excess of Blasts
- Anemia, Sickle Cell
- Astrocytoma
- Bile Duct Neoplasms
- Blast Crisis
- Brain Neoplasms
- Breast Carcinoma In Situ
- Breast Neoplasms
- Breast Neoplasms, Male
- Burkitt Lymphoma
- Calcinosis
- Carcinoma
- Carcinoma, Acinar Cell
- Carcinoma, Ductal, Breast
- Carcinoma, Hepatocellular
- Carcinoma in Situ
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Lobular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Small Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Central Nervous System Neoplasms
- Cholangiocarcinoma
- Chondrosarcoma
- Colonic Neoplasms
- Colorectal Neoplasms
- Cytomegalovirus Infections
- Desmoplastic Small Round Cell Tumor
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Disease
- Endometrial Neoplasms
- Enteropathy-Associated T-Cell Lymphoma
- Ependymoma
- Esophageal Neoplasms
- Esophageal Squamous Cell Carcinoma
- Fallopian Tube Neoplasms
- Fractures, Stress
- Gallbladder Neoplasms
- Glioblastoma
- Glioma
- Gliosarcoma
- Graft vs Host Disease
- Head and Neck Neoplasms
- Heart Failure
- Hemangiopericytoma
- Hematologic Diseases
- Hematologic Neoplasms
- Hemoglobinopathies
- Hemolysis
- Hepatitis C
- Hodgkin Disease
- Hypereosinophilic Syndrome
- Hyperplasia
- Immunoblastic Lymphadenopathy
- Infections
- Inflammatory Breast Neoplasms
- Intestinal Diseases
- Intestinal Neoplasms
- Intraocular Lymphoma
- Kidney Neoplasms
- Laboratory Infection
- Leukemia
- Leukemia, Biphenotypic, Acute
- Leukemia, Erythroblastic, Acute
- Leukemia, Hairy Cell
- Leukemia, Large Granular Lymphocytic
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia-Lymphoma, Adult T-Cell
- Leukemia, Megakaryoblastic, Acute
- Leukemia, Monocytic, Acute
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Accelerated Phase
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
- Leukemia, Myeloid, Chronic-Phase
- Leukemia, Myelomonocytic, Acute
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myelomonocytic, Juvenile
- Leukemia, Plasma Cell
- Leukemia, Prolymphocytic
- Leukemia, Prolymphocytic, B-Cell
- Leukemia, Promyelocytic, Acute
- Leukemia, T-Cell
- Liposarcoma
- Liver Diseases
Recent trials (50)
- NCT07061574Lead sponsorPhase 1/Phase 2Dec 15, 2026
- NCT07061574OfficialPhase 1/Phase 2Dec 15, 2026
- NCT07288034OfficialPhase 2Sep 21, 2026
- NCT07288034Lead sponsorPhase 2Sep 21, 2026
- NCT07218692OfficialPhase 2Aug 11, 2026
- NCT07218692Lead sponsorPhase 2Aug 11, 2026
- NCT07271355OfficialPhase 3Jul 1, 2026
- NCT07275216Lead sponsorPhase 2Jul 1, 2026
- NCT07275216OfficialPhase 2Jul 1, 2026
- NCT07271355Lead sponsorPhase 3Jul 1, 2026
- NCT07226544OfficialPhase 2Jun 8, 2026
- NCT07226544Lead sponsorPhase 2Jun 8, 2026
- NCT07293403Lead sponsorPhase 2Jun 7, 2026
- NCT07293403OfficialPhase 2Jun 7, 2026
- NCT06996119OfficialPhase 1May 25, 2026
Details
- Founded
- Los Angeles, CA, US Jan 1, 1913
- Last known activity
- Dec 15, 2026